Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

N-Acetyl Cysteine add-on to Antidepressant Medication in Therapy Refractory Major Depressive Disorder Patients With Increased Inflammatory Activity

NCT02972398 is registered in ClinicalTrials.gov with Tianjin Anding Hospital as lead sponsor.

NCT NCT02972398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02972398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
N-Acetyl Cysteine add-on to Antidepressant Medication in Therapy Refractory Major Depressive Disorder Patients With Increased Inflammatory Activity
Lead sponsor
Tianjin Anding Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2015
Completion date
September 30, 2023
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorders